SEROQUEL - 0310-0279-39 - (Quetiapine fumarate)

Alphabetical Index


Drug Information of SEROQUEL

Product NDC: 0310-0279
Proprietary Name: SEROQUEL
Non Proprietary Name: Quetiapine fumarate
Active Ingredient(s): 400    mg/1 & nbsp;   Quetiapine fumarate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of SEROQUEL

Product NDC: 0310-0279
Labeler Name: AstraZeneca Pharmaceuticals LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020639
Marketing Category: NDA
Start Marketing Date: 20060213

Package Information of SEROQUEL

Package NDC: 0310-0279-39
Package Description: 10 BLISTER PACK in 1 CARTON (0310-0279-39) > 10 TABLET, FILM COATED in 1 BLISTER PACK

NDC Information of SEROQUEL

NDC Code 0310-0279-39
Proprietary Name SEROQUEL
Package Description 10 BLISTER PACK in 1 CARTON (0310-0279-39) > 10 TABLET, FILM COATED in 1 BLISTER PACK
Product NDC 0310-0279
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Quetiapine fumarate
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20060213
Marketing Category Name NDA
Labeler Name AstraZeneca Pharmaceuticals LP
Substance Name QUETIAPINE FUMARATE
Strength Number 400
Strength Unit mg/1
Pharmaceutical Classes Atypical Antipsychotic [EPC]

Complete Information of SEROQUEL


General Information